Martin Ogrodzinski
Clinical FellowDownloadHi-Res Photo
About
Copy Link
Titles
Clinical Fellow
Departments & Organizations
- All Institutions
- Internal Medicine
Education & Training
- Resident
- Case Western Reserve School of Medicine (2025)
- MD
- Michigan State University (2022)
Board Certifications
Interanl Medicine
- Certification Organization
- ABIM
- Original Certification Date
- 2025
Research
Copy Link
Research at a Glance
Publications Timeline
A big-picture view of Martin Ogrodzinski's research output by year.
5Publications
Publications
2022
Counterion Tuning of Near-Infrared Organic Salts Dictates Phototoxicity to Inhibit Tumor Growth.
Broadwater D, C D Medeiros H, Bates M, Roshanzadeh A, Thing Teoh S, P Ogrodzinski M, Borhan B, Lunt RR, Lunt SY. Counterion Tuning of Near-Infrared Organic Salts Dictates Phototoxicity to Inhibit Tumor Growth. ACS Appl Mater Interfaces 2022, 14: 53511-53522. PMID: 36408853, DOI: 10.1021/acsami.2c16252.Peer-Reviewed Original Research
2021
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.
Panwalkar P, Tamrazi B, Dang D, Chung C, Sweha S, Natarajan SK, Pun M, Bayliss J, Ogrodzinski MP, Pratt D, Mullan B, Hawes D, Yang F, Lu C, Sabari BR, Achreja A, Heon J, Animasahun O, Cieslik M, Dunham C, Yip S, Hukin J, Phillips JJ, Bornhorst M, Griesinger AM, Donson AM, Foreman NK, Garton HJL, Heth J, Muraszko K, Nazarian J, Koschmann C, Jiang L, Filbin MG, Nagrath D, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Allis CD, Chinnaiyan AM, Lunt SY, Blüml S, Judkins AR, Venneti S. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas. Sci Transl Med 2021, 13: eabc0497. PMID: 34613815, DOI: 10.1126/scitranslmed.abc0497.Peer-Reviewed Original ResearchTargeting Subtype-Specific Metabolic Preferences in Nucleotide Biosynthesis Inhibits Tumor Growth in a Breast Cancer Model.
Ogrodzinski MP, Teoh ST, Lunt SY. Targeting Subtype-Specific Metabolic Preferences in Nucleotide Biosynthesis Inhibits Tumor Growth in a Breast Cancer Model. Cancer Res 2021, 81: 303-314. PMID: 33115804, DOI: 10.1158/0008-5472.CAN-20-1666.Peer-Reviewed Original Research
2020
Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes.
Ogrodzinski MP, Teoh ST, Lunt SY. Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes. Cell Oncol (Dordr) 2020, 43: 1117-1127. PMID: 32691367, DOI: 10.1007/s13402-020-00545-1.Peer-Reviewed Original Research
2019
Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells.
Yu L, Teoh ST, Ensink E, Ogrodzinski MP, Yang C, Vazquez AI, Lunt SY. Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells. Cancer Metab 2019, 7: 13. PMID: 31893043, DOI: 10.1186/s40170-019-0205-z.Peer-Reviewed Original Research
News
Copy Link